The PAI-1-specific inhibitor appeared to exhibit therapeutic effects by rescuing muscle atrophy through inhibition of PAI-1, which is a contributory factor of irradiated GBM-induced cachexia. The gene discussed is SERPINE1; the disease is glioblastoma.